Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Opinion on Drug Delivery|June 23, 2022
Protein corona: challenges and opportunities for targeted delivery of nanomedicinesZhuxuan Jiang, Yuxiu Chu, Changyou ZhanJournal of Controlled Release : Official Journal of the Controlled Release Society|July 8, 2024
Brain-targeted drug delivery by in vivo functionalized liposome with stable D-peptide ligandYang Yang, Yuxiu Chu, Cheng Li, et al.Nano Letters|November 23, 2021
Facile Separation of PEGylated Liposomes Enabled by Anti-PEG scFvWenjing Tang, Zui Zhang, Cheng Li, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2020
Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicinesZui Zhang, Yuxiu Chu, Cheng Li, et al.Nano Letters|February 22, 2021
Deciphering Protein Corona by scFv-Based Affinity ChromatographyYuxiu Chu, Wenjing Tang, Zui Zhang, et al.Advanced Healthcare Materials|March 28, 2023
Lipid-Based Nanocarriers Enabled Oral Delivery of Oleanolic Acid Derivative DKS26 for Diabetes ManagementYujuan Ban, Yuxiu Chu, Feng Pan, et al.Journal of Medicinal Chemistry|April 25, 2024
Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human Breast CancerQiwen Sun, Yuxiu Chu, Nana Zhang, et al.Acta Pharmaceutica Sinica. B|December 12, 2024
Exemplifying interspecies variation of liposome <i>in vivo</i> fate by the effects of anti-PEG antibodiesErcan Wu, Juan Guan, Yifei Yu, et al.Molecular Pharmaceutics|April 12, 2024
Phospholipid Type Regulates Protein Corona Composition and <i>In Vivo</i> Performance of Lipid NanodiscsFeng Pan, Mengyuan Liu, Guanghui Li, et al.Pageof 1